Crizotinib Targets ALK-Driven Cancers

Really exciting and encouraging results in a phase 1 clinical trial for a pill, Crizotinib, in children with Neuroblastoma!
Read the full article: Crizotinib Targets ALK-Driven Cancers in Pediatric Trial